Cleared Traditional

K231603 - Standard Staple-Line Reinforcement (SSLR23) (FDA 510(k) Clearance)

Oct 2023
Decision
127d
Days
Class 2
Risk

K231603 is an FDA 510(k) clearance for the Standard Staple-Line Reinforcement (SSLR23). This device is classified as a Mesh, Surgical, Absorbable, Staple Line Reinforcement (Class II - Special Controls, product code OXC).

Submitted by Standard Bariatrics, Inc. (Cincinnati, US). The FDA issued a Cleared decision on October 6, 2023, 127 days after receiving the submission on June 1, 2023.

This device falls under the General & Plastic Surgery FDA review panel. Regulated under 21 CFR 878.3300. For Reinforcement Of Soft Tissue Where Weakness Exists During Staple Line Reinforcement Procedures..

Submission Details

510(k) Number K231603 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 01, 2023
Decision Date October 06, 2023
Days to Decision 127 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF

Device Classification

Product Code OXC - Mesh, Surgical, Absorbable, Staple Line Reinforcement
Device Class Class II - Special Controls
CFR Regulation 21 CFR 878.3300
Definition For Reinforcement Of Soft Tissue Where Weakness Exists During Staple Line Reinforcement Procedures.